These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26439917)

  • 41. Using Digital Technologies in Clinical HIV Research: Real-World Applications and Considerations for Future Work.
    Andriesen J; Bull S; Dietrich J; Haberer JE; Van Der Pol B; Voronin Y; Wall KM; Whalen C; Priddy F
    J Med Internet Res; 2017 Jul; 19(7):e274. PubMed ID: 28760729
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring.
    Lifson MA; Ozen MO; Inci F; Wang S; Inan H; Baday M; Henrich TJ; Demirci U
    Adv Drug Deliv Rev; 2016 Aug; 103():90-104. PubMed ID: 27262924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An exploration of weekly patterns in HIV-related behaviors: implications for successful interventions and future research.
    Fuentes LW; Johnson ML; Holtgrave DR
    AIDS Care; 2015; 27(9):1118-27. PubMed ID: 25894315
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peer mentors, mobile phone and pills: collective monitoring and adherence in Kenyatta National Hospital's HIV treatment programme.
    Moyer E
    Anthropol Med; 2014; 21(2):149-61. PubMed ID: 25175291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Examining theoretic models of adherence for validity in resource-limited settings. A heuristic approach.
    Ware NC; Wyatt MA; Bangsberg DR
    J Acquir Immune Defic Syndr; 2006 Dec; 43 Suppl 1():S18-22. PubMed ID: 17133200
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities.
    Subbaraman R; de Mondesert L; Musiimenta A; Pai M; Mayer KH; Thomas BE; Haberer J
    BMJ Glob Health; 2018; 3(5):e001018. PubMed ID: 30364330
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Real-time monitoring through the use of technology to enhance performances throughout HIV cascades.
    Avery M; Mills SJ; Stephan E
    Curr Opin HIV AIDS; 2017 Sep; 12(5):488-493. PubMed ID: 28650346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of telemedicine in the management of infectious diseases.
    Gras G
    Med Mal Infect; 2018 Jun; 48(4):231-237. PubMed ID: 29452936
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multidimensional conceptual framework for understanding HIV/AIDS as a chronic long-term illness.
    Mitchell CG; Linsk NL
    Soc Work; 2004 Jul; 49(3):469-77. PubMed ID: 15281702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Strategies for promoting adherence to antiretroviral therapy: a review of the literature.
    Simoni JM; Amico KR; Pearson CR; Malow R
    Curr Infect Dis Rep; 2008 Nov; 10(6):515-21. PubMed ID: 18945394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monitoring Antiretroviral Therapy in HIV-Infected Children in Resource-Limited Countries: A Tale of Two Epidemics.
    Paintsil E
    AIDS Res Treat; 2011; 2011():280901. PubMed ID: 21490777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Implementation research on HIV adherence interventions: no time to wait.
    Simoni JM; Aunon FM; Kemp CG; Kutner BA; Ramaiya MK; Velloza J; Yang JP
    Lancet Infect Dis; 2017 Jun; 17(6):564-565. PubMed ID: 28262600
    [No Abstract]   [Full Text] [Related]  

  • 53. Impact of automated data flow and reminders on adherence and resource utilization for remotely monitoring physical activity in individuals with stroke or chronic obstructive pulmonary disease.
    French MA; Balasubramanian A; Hansel NN; Penttinen SK; Wise R; Raghavan P; Wegener ST; Roemmich RT; Celnik PA
    medRxiv; 2024 Apr; ():. PubMed ID: 38699312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human Immunodeficiency Virus Resistance Testing Technologies and Their Applicability in Resource-Limited Settings of Africa.
    Nasir IA; Emeribe AU; Ojeamiren I; Aderinsayo Adekola H
    Infect Dis (Auckl); 2017; 10():1178633717749597. PubMed ID: 29308013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clustering functional data with application to electronic medication adherence monitoring in HIV prevention trials.
    Zhu Y; Di C; Chen YQ
    Stat Biosci; 2019 Jul; 11(2):238-261. PubMed ID: 31693010
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optical imaging technologies for
    Hou H; Mitbander R; Tang Y; Azimuddin A; Carns J; Schwarz RA; Richards-Kortum RR
    Curr Opin Biomed Eng; 2023 Dec; 28():. PubMed ID: 38406798
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent advances and novel concepts in environmental technologies.
    Rene ER; Shu L; Jegatheesan V
    Environ Sci Pollut Res Int; 2020 Jul; 27(20):24591-24593. PubMed ID: 32274696
    [No Abstract]   [Full Text] [Related]  

  • 58. Innovative approaches to clinical data management in resource limited settings using open-source technologies.
    Omollo R; Ochieng M; Mutinda B; Omollo T; Owiti R; Okeyo S; Wasunna M; Edwards T
    PLoS Negl Trop Dis; 2014 Sep; 8(9):e3134. PubMed ID: 25210976
    [No Abstract]   [Full Text] [Related]  

  • 59. Limited evidence for low-cost devices to improve adherence.
    Drug Ther Bull; 2017 May; 55(5):50-51. PubMed ID: 28465367
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.